December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Enes Erul: Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors
May 9, 2024, 00:21

Enes Erul: Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors

Enes Erul, Oncology Fellow at Ankara Üniversitesi, shared on X:

“Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors, with a 29.4% objective response rate in heavily treated patients. Safety profile manageable, supporting further investigation across tumor types.

Enes Erul Enes Erul

Source: Enes Erul/X